163 related articles for article (PubMed ID: 10526548)
1. Methadone maintenance and state Medicaid managed care programs.
McCarty D; Frank RG; Denmead GC
Milbank Q; 1999; 77(3):341-62, 274. PubMed ID: 10526548
[TBL] [Abstract][Full Text] [Related]
2. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
Maglione M; Ridgely MS
J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
[TBL] [Abstract][Full Text] [Related]
3. Retention in publicly funded methadone maintenance treatment in two Western States.
Deck D; Carlson MJ
J Behav Health Serv Res; 2005; 32(1):43-60. PubMed ID: 15632797
[TBL] [Abstract][Full Text] [Related]
4. Medicaid coverage of medications to treat alcohol and opioid dependence.
Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J
J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475
[TBL] [Abstract][Full Text] [Related]
5. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
Saloner B; Stoller KB; Barry CL
Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
[TBL] [Abstract][Full Text] [Related]
6. Implications of managed care for methadone treatment. Findings from five case studies in New York State.
Zarkin GA; Dunlap LJ
J Subst Abuse Treat; 1999; 17(1-2):25-35. PubMed ID: 10435250
[TBL] [Abstract][Full Text] [Related]
7. Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.
Bachhuber MA; Mehta PK; Faherty LJ; Saloner B
Med Care; 2017 Dec; 55(12):985-990. PubMed ID: 29135769
[TBL] [Abstract][Full Text] [Related]
8. Availability of nutrition services for Medicaid recipients in the northeastern United States: lack of uniformity and the positive effect of managed care.
Tsai AG; Mansukani S; Cucchiara A; Schaffer M
Am J Manag Care; 2003 Dec; 9(12):817-21. PubMed ID: 14712758
[TBL] [Abstract][Full Text] [Related]
9. State variation in opioid treatment policies and opioid-related hospital readmissions.
Blanchard J; Weiss AJ; Barrett ML; McDermott KW; Heslin KC
BMC Health Serv Res; 2018 Dec; 18(1):971. PubMed ID: 30558595
[TBL] [Abstract][Full Text] [Related]
10. Medicaid managed care and the family planning free-choice exemption: beyond the freedom to choose.
Rosenbaum S; Shin PW; Mauskopf A; Zuvekas A
J Health Polit Policy Law; 1997 Oct; 22(5):1191-214. PubMed ID: 9394245
[TBL] [Abstract][Full Text] [Related]
11. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
Clark RE; Baxter JD; Aweh G; O'Connell E; Fisher WH; Barton BA
J Subst Abuse Treat; 2015 Oct; 57():75-80. PubMed ID: 25997674
[TBL] [Abstract][Full Text] [Related]
13. Financial factors and the implementation of medications for treating opioid use disorders.
Knudsen HK; Roman PM
J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
[TBL] [Abstract][Full Text] [Related]
14. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.
Colby MS; Lipson DJ; Turchin SR
Matern Child Health J; 2012 Apr; 16 Suppl 1():S51-60. PubMed ID: 22476794
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for medicaid clients with substance abuse problems before and after managed care.
McFarland BH; Deck DD; McCamant LE; Gabriel RM; Bigelow DA
J Behav Health Serv Res; 2005; 32(4):351-67. PubMed ID: 16215446
[TBL] [Abstract][Full Text] [Related]
16. On-site medical care in methadone maintenance: associations with health care use and expenditures.
Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
[TBL] [Abstract][Full Text] [Related]
17. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
Trafton JA; Tracy SW; Oliva EM; Humphreys K
J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
[TBL] [Abstract][Full Text] [Related]
18. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
[TBL] [Abstract][Full Text] [Related]
20. Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states.
Deck D; Wiitala W; McFarland B; Campbell K; Mullooly J; Krupski A; McCarty D
J Addict Dis; 2009; 28(2):89-102. PubMed ID: 19340671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
